In May 2011, Lankenau and Baldwin Management, LLC, presented a unique
conversation-style event that was the first in what will be a biannual
series that blends discussion of research and patient care with
investment opportunities in the biotech field.
A Conversation about Cancer: Emerging Science, Treatments and Technology
was the brainchild of and hosted by Peter Havens, Chairman of the
Lankenau Institute for Medical Research (LIMR); Trustee of Lankenau
Medical Center (LMC) and Main Line Health (MLH); and Chairman of
investment firm, Baldwin Management, LLC.
The Conversation, co-hosted by Lankenau President, Phil Robinson,
attracted an audience of more than 100 and was followed by a reception
with guided tours of the technology, discussed during the program, and a
LIMR research laboratory.
Panelists George Prendergast, President, LIMR; Dr. John Marks, Chief of
Colorectal Surgery, LMC and Main Line Health (MLH); Dr. Marisa Weiss,
Director of Breast Radiation Oncology and Breast Health Outreach, LMC,
and founder of Breastcancer.org; and Dr. Devang Kantesaria, Lankenau
Trustee and General Partner with Devon Park Bioventures, fielded
questions from the audience and gave their input on the current status
and future of cancer prevention and treatment, and the investment
climate within this industry.
Lankenau Medical Center Development Office
100 E. Lancaster Avenue
MOB East, Suite 564
Wynnewood, PA 19096
For more information, call 1.866.CALL.MLH.